Srs Capital Advisors, Inc. Immunity Bio, Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 844 shares of IBRX stock, worth $3,038. This represents 0.0% of its overall portfolio holdings.
Number of Shares
844
Previous 600
40.67%
Holding current value
$3,038
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IBRX
# of Institutions
216Shares Held
63.3MCall Options Held
1.43MPut Options Held
4.12M-
Vanguard Group Inc Valley Forge, PA13.8MShares$49.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$41.1 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$28.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$14.1 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$6.18 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.44B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...